Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Core One Labs Inc
Bullboard Posts
User Avatar Image
(51)
•••
Comment by kooter33on Dec 03, 2017 12:07pm
141 Views
Post# 27080426

RE:RE:RE:RE:RE:RE:RE:RE:Short Report

RE:RE:RE:RE:RE:RE:RE:RE:Short Report
sandra2017 wrote:
Seeing the cessation and outcome of the incident, with production resuming almost immediately, and November's numbers due soon, I don't see a reason for a dip in share price. I can't predict the future but I think the conditions are ripe for a squeeze. Does anyone know how long the shorts have to cover?

You can probably garner that info from the short.ca website, but in reality WHEN the October/Nov sales numbers come out, there won't be a lot of time for them to cover.  I suspect they will push to take it down early Monday with some covering in the PM, IF LDS is trading Monday.  If LDS does trade Monday I will be there to catch the down draft IF there is one.
GL.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities